StonvexLoading…
StonvexStonvexStonvexCore line items from CAMT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $496.07M | $429.23M | $315.38M | $320.91M |
Operating Income | $128.20M | $108.07M | $65.41M | $81.50M |
Net Income | $50.72M | $118.52M | $78.63M | $79.95M |
EPS (Diluted) | $1.04 | $2.42 | $1.63 | $1.68 |
Total Assets | $1.26B | $892.04M | $787.67M | $677.09M |
Total Liabilities | $642.83M | $342.81M | $311.52M | $292.99M |
Cash & Equivalents | $177.85M | $126.22M | $119.97M | $148.16M |
Free Cash Flow OCF − CapEx | $127.47M | $112.14M | $71.23M | $49.60M |
Shares Outstanding | 45.83M | 45.45M | 44.90M | 44.41M |